William E. Duke's Net Worth
$24.1 Thousand
Who is William E. Duke?
William E. Duke does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kaleido Biosciences, Inc., Pulmatrix, Inc., Apexigen, Inc., and Invivyd, Inc..
SEC CIK
William E. Duke's CIK is 0001636135
Past Insider Trading and Trends
2022 was William E. Duke's most active year for acquiring shares with 4 total transactions. William E. Duke's most active month to acquire stocks was the month of September. 2023 was William E. Duke's most active year for disposing of shares, totalling 5 transactions. William E. Duke's most active month to dispose stocks was the month of July. 2018 saw William E. Duke paying a total of $0.00 for 850,000 shares, this is the most they've acquired in one year. In 2023 William E. Duke cashed out on 446,030 shares for a total of $19,289.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pulmatrix, Inc. (PULM) Snapshot price: $1.7574
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apexigen, Inc. No price found
Chief Financial OfficerWilliam E. Duke used to own units in Common Stock but no longer holds any shares there. In the year 2022 William E. Duke acquired a total of 180,685 shares in Apexigen, Inc., William also disposed a total of 180,685 shares of Apexigen, Inc. equalling to $24,062.29.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -154.42K |
$0.39 |
—
|
0
|
Aug 23
| |||
Form 4
| -2.83% | -4.50K |
$0.49 | -$2,211.91 | 154.42K |
Jun 15
| |||
Form 4
| +506.99% | 132.74K |
$0.40 | -$6,904.40 | 158.92K |
May 23
| |||
Form 4
| -14.67% | -4.50K |
$1.06 | -$4,773.18 | 26.18K |
Dec 15
| |||
Form 4
|
∞
| 30.68K |
—
|
—
| 30.68K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Invivyd, Inc. (IVVD) Snapshot price: $4.74
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||